Shankar, Puja
Mueller, Ariel
Packiasabapathy, Senthil
Gasangwa, Doris
Patxot, Melissa
O’Gara, Brian
Shaefi, Shahzad
Marcantonio, Edward R.
Subramaniam, Balachundhar
Funding for this research was provided by:
Mallinckrodt Pharmaceuticals
Article History
Received: 23 January 2018
Accepted: 1 June 2018
First Online: 22 June 2018
Ethics approval and consent to participate
: This study has been approved by the Committee on Clinical Investigations Institutional Review Board at Beth Israel Deaconess Medical Center (Protocol 2014-P-000413). Written informed consent will be obtained from all subjects prior to initiation of study procedures by a trained study staff member. This will include discussion about all the aspects of the study, including drug intervention, assessments, follow-up, and acquisition and storage of blood samples.
: Not applicable.
: The principal investigator is supported by National Institutes of Health Research Project Grant GM 098406. The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.